l-carnitine tmao koeth 2013 nature medicine

l-carnitine tmao koeth 2013 nature medicine γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of to Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis:

Name: l-carnitine tmao koeth 2013 nature medicine γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of to Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis:
Brand: www.marsberger-treibhaus.de
SKU: 91883648592
Price: 24.08 USD
Availability: InStock
Rating: 4.7254000000000005 (10 reviews)

Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy Frontiers Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism Frontiers TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review Intestinal microbiota metabolism of l carnitine, a nutrient in red meat, promotes atherosclerosis Nature Medicine

SKU: 91883648592 · From www.marsberger-treibhaus.de

4.7

USD24.08 USD64.08

Pay in 4 interest-free payments of $6.02 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

doi: 10.1038/ja.2017.11

l-carnitine tmao koeth 2013 nature medicine Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of to Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis:

Monfrini, M

L-carnitina y interacciones con medicamentos La carnitina interacta con antibiticos conjugados con pivalato, como la Pivampicilina, que se utilizan en la prevencin a largo plazo de infecciones del tracto urinario